山东药玻
(600529)
| 流通市值：146.13亿 | | | 总市值：146.13亿 |
| 流通股本：6.64亿 | | | 总股本：6.64亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,242,455,243.5 | 5,125,270,640.68 | 3,824,950,899.24 | 2,585,950,518.3 |
| 营业收入 | 1,242,455,243.5 | 5,125,270,640.68 | 3,824,950,899.24 | 2,585,950,518.3 |
| 二、营业总成本 | 982,600,179.31 | 4,013,019,482.72 | 2,966,963,655.72 | 1,999,640,334.24 |
| 营业成本 | 867,166,737.37 | 3,499,338,477.09 | 2,597,119,472.67 | 1,749,380,728.23 |
| 税金及附加 | 10,446,215.51 | 54,549,603.3 | 40,707,950.22 | 28,665,969.5 |
| 销售费用 | 20,893,173.48 | 129,736,903.09 | 92,248,624.66 | 61,957,528.83 |
| 管理费用 | 41,187,436.65 | 215,768,838.57 | 146,586,178.09 | 105,793,713.39 |
| 研发费用 | 49,680,967.32 | 151,763,172.77 | 115,324,642.87 | 77,647,127.24 |
| 财务费用 | -6,774,351.02 | -38,137,512.1 | -25,023,212.79 | -23,804,732.95 |
| 其中:利息费用 | 4,942.62 | 25,183.45 | 19,912.84 | 15,312.54 |
| 其中:利息收入 | 3,526,865.62 | 21,211,803.93 | 18,637,370.01 | 13,203,130.27 |
| 加:公允价值变动收益 | 4,105,310.68 | 24,463,237.31 | 19,843,946.28 | 14,217,607.7 |
| 加:投资收益 | 3,986,280.22 | 11,633,529.78 | 9,219,631.55 | 5,281,521.52 |
| 资产处置收益 | 109.46 | 329,546.95 | 329,075.59 | 254,780.79 |
| 资产减值损失(新) | - | -61,157,836.83 | -30,162,527.45 | -30,162,527.45 |
| 信用减值损失(新) | -6,196,742.54 | -1,283,636.72 | -4,125,156.64 | -3,470,832.08 |
| 其他收益 | 5,089,395.49 | 26,524,819.35 | 20,103,532.17 | 10,858,719.55 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 266,839,417.5 | 1,112,760,817.8 | 873,195,745.02 | 583,289,454.09 |
| 加:营业外收入 | 868,048.55 | 3,398,144.75 | 2,656,470.78 | 2,171,066.29 |
| 减:营业外支出 | 792,935.38 | 5,353,909.36 | 3,653,076.07 | 3,337,777.89 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 266,914,530.67 | 1,110,805,053.19 | 872,199,139.73 | 582,122,742.49 |
| 减:所得税费用 | 43,285,095.79 | 167,813,747.78 | 151,767,993.07 | 106,956,098.89 |
| 六、净利润 | 223,629,434.88 | 942,991,305.41 | 720,431,146.66 | 475,166,643.6 |
| 持续经营净利润 | 223,629,434.88 | 942,991,305.41 | 720,431,146.66 | 475,166,643.6 |
| 归属于母公司股东的净利润 | 223,629,434.88 | 942,991,305.41 | 720,431,146.66 | 475,166,643.6 |
| (一)基本每股收益 | 0.34 | 1.42 | 1.09 | 0.72 |
| (二)稀释每股收益 | 0.34 | 1.42 | 1.09 | 0.72 |
| 九、综合收益总额 | 223,629,434.88 | 942,991,305.41 | 720,431,146.66 | 475,166,643.6 |
| 归属于母公司股东的综合收益总额 | 223,629,434.88 | 942,991,305.41 | 720,431,146.66 | 475,166,643.6 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-29 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |